Treatment Arm
Visit number vs Active Ghrelin
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 48 | 270.8 | ± 224.1 | 197.5 | 33.0 | 1,249.0 | 1 | 49 |
9-Month Followup | 41 | 248.3 | ± 212.7 | 188.0 | 27.0 | 928.0 | 2 | 43 |
18-Month Followup | 38 | 204.3 | ± 134.9 | 168.0 | 53.0 | 737.0 | 2 | 40 |
Randomized treatment arm vs Active Ghrelin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 48 | 270.8 | ± 224.1 | 197.5 | 33.0 | 1,249.0 | 1 | 49 |
Laparoscopic Gastric Banding (LGB) | 27 | 289.5 | ± 261.3 | 225.0 | 36.0 | 1,249.0 | 1 | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 246.7 | ± 167.9 | 191.0 | 33.0 | 716.0 | - | 21 |
Randomized treatment arm vs Active Ghrelin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 41 | 248.3 | ± 212.7 | 188.0 | 27.0 | 928.0 | 2 | 43 |
Laparoscopic Gastric Banding (LGB) | 23 | 223.8 | ± 207.4 | 154.0 | 27.0 | 848.0 | 2 | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 279.6 | ± 221.3 | 211.5 | 56.0 | 928.0 | - | 18 |
Randomized treatment arm vs Active Ghrelin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 38 | 204.3 | ± 134.9 | 168.0 | 53.0 | 737.0 | 2 | 40 |
Laparoscopic Gastric Banding (LGB) | 22 | 196.3 | ± 153.9 | 142.0 | 53.0 | 737.0 | 2 | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 215.3 | ± 107.4 | 188.0 | 74.0 | 471.0 | - | 16 |
Age of the participant vs Active Ghrelin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 48 | 270.8 | ± 224.1 | 197.5 | 33.0 | 1,249.0 | 1 | 49 |
27.0 to 45.0 years | 13 | 369.4 | ± 319.5 | 275.0 | 33.0 | 1,249.0 | - | 13 |
46.0 to 50.0 years | 11 | 270.2 | ± 219.9 | 151.0 | 96.0 | 692.0 | 1 | 12 |
51.0 to 56.0 years | 12 | 226.7 | ± 138.3 | 196.0 | 48.0 | 474.0 | - | 12 |
57.0 to 65.0 years | 12 | 208.7 | ± 149.5 | 165.5 | 36.0 | 574.0 | - | 12 |
Age of the participant vs Active Ghrelin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 41 | 248.3 | ± 212.7 | 188.0 | 27.0 | 928.0 | 2 | 43 |
28.0 to 47.0 years | 11 | 389.5 | ± 249.5 | 287.0 | 142.0 | 928.0 | - | 11 |
47.0 to 52.0 years | 11 | 200.5 | ± 146.8 | 154.0 | 56.0 | 525.0 | - | 11 |
52.0 to 58.0 years | 10 | 237.7 | ± 240.6 | 146.0 | 60.0 | 848.0 | 1 | 11 |
58.0 to 65.0 years | 9 | 146.0 | ± 118.1 | 114.0 | 27.0 | 404.0 | 1 | 10 |
Age of the participant vs Active Ghrelin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 38 | 204.3 | ± 134.9 | 168.0 | 53.0 | 737.0 | 2 | 40 |
29.0 to 46.0 years | 10 | 270.2 | ± 182.8 | 176.5 | 146.0 | 737.0 | - | 10 |
47.0 to 52.0 years | 10 | 223.1 | ± 141.6 | 142.0 | 74.0 | 471.0 | - | 10 |
53.0 to 58.0 years | 10 | 164.7 | ± 73.0 | 178.0 | 58.0 | 289.0 | - | 10 |
58.0 to 65.0 years | 8 | 147.9 | ± 89.9 | 129.0 | 53.0 | 336.0 | 2 | 10 |
Gender of the participant vs Active Ghrelin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 48 | 270.8 | ± 224.1 | 197.5 | 33.0 | 1,249.0 | 1 | 49 |
Male | 28 | 313.0 | ± 242.9 | 233.0 | 119.0 | 1,249.0 | - | 28 |
Female | 20 | 211.8 | ± 184.7 | 116.5 | 33.0 | 692.0 | 1 | 21 |
Gender of the participant vs Active Ghrelin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 41 | 248.3 | ± 212.7 | 188.0 | 27.0 | 928.0 | 2 | 43 |
Male | 23 | 266.0 | ± 230.9 | 213.0 | 27.0 | 928.0 | 2 | 25 |
Female | 18 | 225.7 | ± 191.1 | 152.0 | 41.0 | 721.0 | - | 18 |
Gender of the participant vs Active Ghrelin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 38 | 204.3 | ± 134.9 | 168.0 | 53.0 | 737.0 | 2 | 40 |
Male | 24 | 228.8 | ± 147.6 | 176.0 | 53.0 | 737.0 | 1 | 25 |
Female | 14 | 162.4 | ± 101.3 | 131.0 | 74.0 | 451.0 | 1 | 15 |
Race of the participant vs Active Ghrelin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 45 | 273.1 | ± 230.5 | 191.0 | 33.0 | 1,249.0 | 1 | 46 |
white | 34 | 277.7 | ± 245.8 | 197.5 | 33.0 | 1,249.0 | 1 | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 234.7 | ± 188.8 | 140.0 | 96.0 | 639.0 | - | 9 |
asian | 2 | 368.5 | ± 164.8 | 368.5 | 252.0 | 485.0 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Active Ghrelin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 38 | 253.9 | ± 219.2 | 186.0 | 27.0 | 928.0 | 2 | 40 |
white | 30 | 270.3 | ± 234.8 | 193.5 | 27.0 | 928.0 | 1 | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 158.7 | ± 113.6 | 130.0 | 41.0 | 385.0 | 1 | 8 |
asian | 1 | 427.0 | - | 427.0 | 427.0 | 427.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Active Ghrelin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 35 | 207.0 | ± 138.8 | 172.0 | 53.0 | 737.0 | 2 | 37 |
white | 28 | 192.7 | ± 130.4 | 168.0 | 53.0 | 737.0 | 1 | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 6 | 244.3 | ± 173.4 | 174.5 | 86.0 | 471.0 | 1 | 7 |
asian | 1 | 384.0 | - | 384.0 | 384.0 | 384.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |